Skip to content

Discontinued — last reported Q3 '22

Debt-to-equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.7×0.0×
Merck & Co. logo
Merck & Co.MRK
1.1×+0.3×
Insmed logo
InsmedINSM
0.8×-10.7×
ALN
Alnylam PharmaceuticalsALNY
0.2×-0.4×
Incyte logo
IncyteINCY
0.0×
Amgen logo
AmgenAMGN
6.2×-3.0×

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23.41B+87.7%
P/E18.2×+7.9×
P/S7.4×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Current ratio4.8×-0.7×

Where this comes from

Calculated from United Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: United Therapeutics’s 10-Q, filed November 2, 2022, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's debt-to-equity?
United Therapeutics (UTHR) reported debt-to-equity of 0× in Q3 2022.
What does debt-to-equity mean?
How much debt the company carries for every dollar of shareholder equity.
How do you interpret debt-to-equity?
Lower is generally safer, but moderate leverage can boost returns. Read in the context of cash-flow stability — a utility tolerates more debt than a cyclical. Negative equity makes the ratio meaningless and it is suppressed there.
How does debt-to-equity compare across companies?
Comparable within an industry; capital structures differ sharply across sectors. Not meaningful for banks.